ClinicalTrials.gg

Eye Diseases clinical trials

The registry lists 388 studies for Eye Diseases across more than 10 countries. 62 are recruiting or about to start. 103 of them are mainly about Eye Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 125 narrower conditions too, such as Cataract: 15,770 studies, 2,631 open.

Get an email when these change. Save the Eye Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
217
Recruiting
53
Status unknown
37
Terminated
33
Active, not recruiting
30
Withdrawn
8

Phase

Phase 2
79
Phase 3
55
Phase 1
51
Phase 4
25
Early Phase 1
4

Where

United States
174
France
46
United Kingdom
39
Germany
37
China
36
Italy
26

What is being tested here

Drugs under test in Eye Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here Antimuscarinics 2 open · Tyrosine kinase inhibitors (TKIs) 1 open · Angiogenesis inhibitors 11 · Corticosteroids 6

Coming up

19studies finish main data collection within a year4 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 53 Eye Diseases studies recruiting now, 36 (68%) set no upper age limit and 8 (15%) stop at 75 or younger. 22 (42%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 19 (36%) take healthy volunteers.

Recruiting studies that take each age, of 53
AgeWomenMen
1017 (32%)17 (32%)
1839 (74%)39 (74%)
3038 (72%)38 (72%)
4038 (72%)38 (72%)
5044 (83%)44 (83%)
6546 (87%)46 (87%)
7546 (87%)46 (87%)
8544 (83%)44 (83%)

Across all 388 studies, recruiting or not: 21% stop at 75 or younger and 15% at 65; 31% take children; 1% are for women only and 1% for men only; 28% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Eye Diseases studies take

Of 28 phase 3 interventional studies under Eye Diseases, half reached primary completion within 25 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 125 mo15–51 · 16 studies——
Phase 219 mo12–29 · 24 studies——
Phase 325 mo20–39 · 28 studies——
Phase 430 mo27–67 · 13 studies——
Interventional, no phase24 mo9–49 · 68 studies—24 mo8–45 · 49 studies
Observational41 mo11–86 · 52 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 388. Browse all 388 → or search them.